BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

BBOT to Participate in Upcoming September Investor Healthcare Conferences

BridgeBio Oncology Therapeutics (BBOT) announced participation in two investor conferences in September, focusing on presenting their clinical-stage biopharmaceutical work targeting RAS-pathway malignancies.